News
This week's top 10 most popular stories on Pharmafile.com!
There is a significant gap in health outcomes between the most and least deprived areas of Scotland, a Scottish government Health and Social care...
November saw the worst A&E performance on record, according to data released by NHS England.
The York-based Aptamer Group is set to expand its premises after securing $2.2 million in overseas investment in June of this year.
Bankrupt drug developer Synergy Pharmaceuticals has announced that the company is to be acquired by Canadian speciality pharma firm Basuch Health...
US firm Merck & Co have announced a collaboration with the Brazilian non-profit Instituto Butantan, with the intention of developing vaccines...
Those living in rural areas are less likely to survive cancer than their city dwelling counterparts, according to new research by the University of...
England’s chief pharmaceutical officer Dr Keith Ridge has been chosen to look into ‘problematic’ overprescribing in the NHS.
The NHS’ cost effectiveness body NICE has rejected two treatments for the rare inherited condition, hereditary transthyretin-related amyliodsis (...
Featuring insight into the treatment and R&D climate for mesothelioma, full-length features on how tech is galvanising precision medicine and how...
